Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | +1.37% | -18.68% | +7.25% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+7.25% | 49.71M | |
-7.50% | 3.08B | |
-4.27% | 172M | |
-11.94% | 85.92M |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International : Completes Preclinical Studies of Medical Cannabis in Multiple Sclerosis; Shares Jump 7%